These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

158 related articles for article (PubMed ID: 9887491)

  • 1. [Testicular tumors. Mortality and recurrence after inadequate therapy].
    Albers P; Dommer K; Müller SC
    Urologe A; 1998 Nov; 37(6):625-8. PubMed ID: 9887491
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Late relapses (>2 years) in patients with stage I testicular germ cell tumors: predictive factors and survival.
    Fedyanin M; Tryakin A; Kanagavel D; Bulanov A; Burova A; Figurin K; Fainshtein I; Sergeev U; Zakharova T; Garin A; Tjulandin S
    Urol Oncol; 2013 May; 31(4):499-504. PubMed ID: 21803619
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Diagnosis and therapy of testicular tumors].
    Albers P
    Urologe A; 2002 Jul; 41(4):374-85; quiz 386-7. PubMed ID: 12214458
    [No Abstract]   [Full Text] [Related]  

  • 4. The pathology of late recurrence of testicular germ cell tumors.
    Michael H; Lucia J; Foster RS; Ulbright TM
    Am J Surg Pathol; 2000 Feb; 24(2):257-73. PubMed ID: 10680894
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clinicopathological features and survival of young Turkish patients with testicular germ cell tumors.
    Ozgun A; Karagoz B; Tuncel T; Emirzeoglu L; Celik S; Bilgi O
    Asian Pac J Cancer Prev; 2013; 14(11):6889-92. PubMed ID: 24377621
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Testicular tumors--a current review].
    Buse S; Lurati G; Schmid HP
    Praxis (Bern 1994); 2003 Nov; 92(47):1989-97. PubMed ID: 14669500
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [What is new in 2011 regarding testicular cancer].
    Krege S
    Urologe A; 2011 Sep; 50 Suppl 1():187-91. PubMed ID: 21837493
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Long-Term Oncologic Outcomes after Primary Retroperitoneal Lymph Node Dissection: Minimizing the Need for Adjuvant Chemotherapy.
    Douglawi A; Calaway A; Tachibana I; Panizzutti Barboza M; Speir R; Masterson T; Adra N; Foster R; Einhorn L; Cary C
    J Urol; 2020 Jul; 204(1):96-103. PubMed ID: 32003612
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Risk-guided after-care of testicular tumor].
    Schölermann KH; Dettmann R; Hartmann M
    Urologe A; 1996 Jul; 35(4):326-30. PubMed ID: 8928363
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Relationship between primary and metastatic testicular germ cell tumors: a clinicopathologic analysis of 100 cases.
    Tarrant WP; Czerniak BA; Guo CC
    Hum Pathol; 2013 Oct; 44(10):2220-6. PubMed ID: 23856516
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Management of stage I testicular seminoma over a period of 49 years.
    Detti B; Scoccianti S; Villari D; Cipressi S; Sardaro A; Simontacchi G; Livi L; Gacci M; Cai T; Greto D; Desideri I; Biti G
    Onkologie; 2011; 34(10):510-4. PubMed ID: 21985849
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clinical profile, treatment and survival outcome of testicular tumors: a pakistani perspective.
    Bhatti AB; Ahmed I; Ghauri RK; Saeed Q; Mir K
    Asian Pac J Cancer Prev; 2014; 15(1):277-80. PubMed ID: 24528039
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Management of testicular seminoma advanced disease. Report on 14 cases and review of the literature.
    Porcaro AB; Antoniolli SZ; Maffei N; Beltrami P; Bassetto MA; Curti P
    Arch Ital Urol Androl; 2002 Jun; 74(2):81-5. PubMed ID: 12161942
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Late relapse (>2 years) on surveillance in stage I non-seminomatous germ cell tumours; predominant seminoma only histology.
    Nolan L; Wheater M; Kirby J; Simmonds P; Mead G
    BJU Int; 2010 Dec; 106(11):1648-51. PubMed ID: 20735393
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Management of clinical stage I testicular pure seminoma. Report on 42 patients and review of the literature.
    Porcaro AB; Antoniolli SZ; Schiavone D; Maffei N; Bassetto MA; Curti P
    Arch Ital Urol Androl; 2002 Jun; 74(2):77-80. PubMed ID: 12161941
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The approach to the patient with synchronous bilateral germ cell tumors: a lesson in oncologic prioritization.
    Feldman DR
    Oncology (Williston Park); 2010 Jul; 24(8):761-3. PubMed ID: 20718258
    [No Abstract]   [Full Text] [Related]  

  • 17. Late relapse of testicular cancer.
    Baniel J; Foster RS; Gonin R; Messemer JE; Donohue JP; Einhorn LH
    J Clin Oncol; 1995 May; 13(5):1170-6. PubMed ID: 7537800
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Surveillance of stage I testicular seminoma: 20 years oncological results].
    Zores T; Mouracade P; Duclos B; Saussine C; Lang H; Jacqmin D
    Prog Urol; 2015 Apr; 25(5):282-7. PubMed ID: 25724863
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A refined risk stratification scheme for clinical stage 1 NSGCT based on evaluation of both embryonal predominance and lymphovascular invasion.
    Lago-Hernandez CA; Feldman H; O'Donnell E; Mahal BA; Perez V; Howard S; Rosenthal M; Cheng SC; Nguyen PL; Beard C; D'Amico AV; Sweeney CJ
    Ann Oncol; 2015 Jul; 26(7):1396-401. PubMed ID: 25888612
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Indolent nonseminomatous germ cell tumor of testis. Prolonged survival of patient with persistent metastatic disease.
    Baker TM; Chan AH; Stutz FH
    Urology; 1986 Apr; 27(4):349-52. PubMed ID: 3008399
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.